Please Wait.....
Report
Chile In Vitro Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
Market Report I 2026-02-09 I 75 Pages I Mordor Intelligence
Chile In Vitro Diagnostics Market Analysis
The Chile in vitro diagnostics market size in 2026 is estimated at USD 211.28 million, growing from 2025 value of USD 202.51 million with 2031 projections showing USD 261.12 million, growing at 4.33% CAGR over 2026-2031. Chile's dual public-private health structure fuels steady test volumes, and its leadership in regional clinical trials adds a constant validation pipeline for new assays. Expansion of reimbursement for molecular tests, aggressive cancer-screening targets, and laboratory automation in Santiago's tertiary centers combine to sustain long-term demand for high-complexity platforms. Exchange-rate exposure inflates reagent costs, yet local manufacturing by long-established multinationals partly cushions supply risks. Regulatory digitization-anchored by HL7 FHIR interoperability rules-further differentiates suppliers that offer connected instruments capable of real-time data exchange.
Chile In Vitro Diagnostics Market Trends and Insights
Growing Chronic-Disease Burden in Chile
Cancer cases are projected to climb 38.3% to 74,973 by 2030 and 74.9% to 94,807 by 2040, amplifying demand for early-detection assays. Diabetes already affects 12.3% of adults, while cardiovascular disease accounts for 27% of deaths, so routine HbA1c, lipid, and troponin panels keep laboratories operating near capacity. The National Cancer Plan 2022-2027 earmarks funds for molecular screening, giving suppliers predictable ordering cycles. Companion-diagnostic validation benefits from Chile's 4.6 clinical trials per million inhabitants, half of which center on oncology. This research ecosystem gives new NGS-based kits local performance evidence, accelerating public-sector adoption via the Instituto de Salud Publica (ISP). Together, epidemiology and policy ensure the Chile in vitro diagnostics market maintains a steady pipeline of high-value tests across hospital and outpatient settings.
FONASA Reimbursement Expansion for Molecular Assays
FONASA's 2024 complementary catalog added tariffs for eight molecular procedures, covering 40% of the fee while FONASA chips in 35%, leaving a 25% copay. Guaranteed HPV molecular screening for adults 35-45 is under evaluation, potentially locking in a recurring public-sector volume exceeding 600,000 tests annually. The ISP's transfer of validated NGS workflows provides a pre-approved pathway for oncology and genetic panels, lowering manufacturers' localization costs. Hospitals see predictable reimbursement, laboratories gain higher-margin menu items, and patients face lower out-of-pocket expenses-all reinforcing the Chile in vitro diagnostics market trajectory.
Delays in ISP Device Approvals
Only 10 device categories are under mandatory control, but a Health-Code overhaul will require Essential-Principles compliance for all IVDs, adding evidence-generation steps. Decree 5 Exempt already forces first-lot testing for immunohematology reagents, hinting at longer lead times for future submissions. While reliance pathways with the FDA or AEMPS exist, high-risk products must still undergo Chilean clinical validation. Companies without local trial capabilities face 6- to 12-month delays, temporarily slowing the Chile in vitro diagnostics market entry of latest-generation analyzers.
Other drivers and restraints analyzed in the detailed report include:
Expansion of Public POC Testing ProgramsDigital Pathology Adoption in Leading Santiago HospitalsPeso Volatility Impacting Imported Reagents Pricing
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Immuno-Diagnostics provided 34.98% of Chile in vitro diagnostics market share in 2025, underpinned by large-volume ELISA and CLIA workflows spanning serology to endocrine panels. Molecular Diagnostics, although smaller, is accelerating at a 8.79% CAGR through 2031, reflecting NGS adoption at the ISP's hematology labs and pathogen-detection upgrades in public hospitals. Clinical Chemistry retains relevance for chronic-disease monitoring, while Hematology sees stable demand from blood-bank modernization under new reagent rules. Microbiology and Urinalysis round out routine testing, safeguarding baseline cash flows for regional labs.
Rapid validation infrastructure-Chile hosts 50% of all Latin-American diagnostic-device trials-provides immediate performance data for emerging nucleic-acid platforms. Harmonization with NCh-ISO 16142 ensures export-ready quality systems, making the Chile in vitro diagnostics market an attractive launchpad for Latin-American expansion. Consequently, molecular menu breadth continues to widen, from respiratory-virus syndromic panels to liquid-biopsy assays.
Reagents & Consumables dominated 59.02% of the Chile in vitro diagnostics market size in 2025, mirroring the recurring-revenue nature of laboratory medicine. Yet instrument sales are growing 8.32% annually, driven by automation needs, digital pathology scanners, and middleware that align with national interoperability mandates. Private networks commit multi-year capex to robotics that cut manual steps, while public hospitals leverage international grants to modernize core labs.
Laboratory Information System projects-RedSalud integrated six regional sites in 2024-favor analyzer lines bundled with HL7 FHIR-ready interfaces. Vendors capable of remote diagnostics and predictive-maintenance analytics hold a competitive edge as the Chile in vitro diagnostics market pivots toward connected care environments.
The Chile in Vitro Diagnostics Market Report is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, and More), Product (Instruments and Reagents & Consumables), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Oncology, and More), and End Users (Diagnostic Laboratories, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Abbott Laboratories Beckton Dickinson bioMerieux Bio-Rad Laboratories BioSystems S.A. Cepheid Inc. DiaSorin Roche Illumina Instrumentation Laboratory Ortho Clinical Diagnostics PerkinElmer QIAGEN Randox Laboratories Siemens Healthineers Sysmex Thermo Fisher Scientific Werfen SA
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Chronic-Disease Burden in Chile
4.2.2 Expansion of Public POC Testing Programs
4.2.3 FONASA Reimbursement Expansion for Molecular Assays
4.2.4 Digital Pathology Adoption in Leading Santiago Hospitals
4.2.5 Emerging Private-Lab Hub Model in Mid-Sized Cities
4.2.6 Mining-Sector Occupational-Health Screening Mandates
4.3 Market Restraints
4.3.1 Delays in ISP (Instituto De Salud Publica) Device Approvals
4.3.2 Peso Volatility Impacting Imported Reagents Pricing
4.3.3 Skilled-Labor Shortages Outside Metropolitan Areas
4.3.4 Low Adoption of LIS Interoperability Standards
4.4 Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitute Products
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Test Type
5.1.1 Clinical Chemistry
5.1.2 Molecular Diagnostics
5.1.3 Immuno-Diagnostics
5.1.4 Hematology
5.1.5 Microbiology
5.1.6 Urinalysis
5.1.7 Other Test Types
5.2 By Product
5.2.1 Instruments
5.2.2 Reagents & Consumables
5.3 By Usability
5.3.1 Disposable IVD Devices
5.3.2 Reusable IVD Devices
5.4 By Application
5.4.1 Infectious Disease
5.4.2 Diabetes
5.4.3 Oncology
5.4.4 Cardiology
5.4.5 Autoimmune
5.4.6 Other Applications
5.5 By End User
5.5.1 Diagnostic Laboratories
5.5.2 Hospitals & Clinics
5.5.3 Other End Users
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 Becton, Dickinson and Company
6.3.3 BioMerieux SA
6.3.4 Bio-Rad Laboratories Inc.
6.3.5 BioSystems S.A.
6.3.6 Cepheid Inc.
6.3.7 DiaSorin SpA
6.3.8 F. Hoffmann-La Roche AG
6.3.9 Illumina Inc.
6.3.10 Instrumentation Laboratory
6.3.11 Ortho Clinical Diagnostics
6.3.12 PerkinElmer Inc.
6.3.13 QIAGEN NV
6.3.14 Randox Laboratories Ltd.
6.3.15 Siemens Healthineers GmbH
6.3.16 Sysmex Corporation
6.3.17 Thermo Fisher Scientific Inc.
6.3.18 Werfen SA
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security